CLDX financials
Celldex Therapeutics (CLDX) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
CLDX income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $1.50M | $1.50M | -$287.40M | -$258.80M | -3.90 |
| 2024 | $7.02M | -$156.53M | -$195.08M | -$157.86M | -2.45 |
| 2023 | $6.88M | -$111.13M | -$154.54M | -$141.43M | -2.92 |
| 2022 | $2.36M | -$79.90M | -$115.23M | -$112.33M | -2.40 |
| 2021 | $4.65M | -$48.66M | -$71.24M | -$70.51M | -1.64 |
| 2020 | $7.42M | -$35.12M | -$63.35M | -$59.78M | -2.02 |
- CLDX revenue was $1.50M in fiscal 2025, net income -$258.80M.
Updated 2026-11-03 11:32 UTC